SURGICAL BLOOD LOSS MEASUREMENT
Majelco Medical Inc. is a University of Utah spin-out, seed -stage company that has developed a proprietary, disposable device to measure accurately surgical blood loss, targeting 10 million moderate blood loss surgeries (MBLS) that take place annually in the USA alone. MBLS are surgeries with an expected, approximate blood loss of 300 – 1500 cc.
Majelco Medical, Inc. is a privately held, prototype-stage medical device company focusing on the development and commercialization of new proprietary methods of measuring blood loss during surgery. The Company was founded in 2014 with the mission to bring much higher precision to infusion and transfusion practices in the operating room, saving patient and provider costs, and significantly improving patient outcomes. The Company continues to seek complimentary business relationships, out-license opportunities and co-development opportunities. Our company includes a team of senior medical professionals and bioengineers, as well as strong, eperienced business leaders with substantial experience in life science technology business development.